Patents Assigned to NBO PHARMA LLC
  • Publication number: 20240131116
    Abstract: Methods and therapeutic combinations are provided for treating idiopathic intracranial hypertension (IIH) and cluster headache, comprising administering a somatostatin mimetic such as octreotide formulated for direct nose-to-brain administration, and a carbonic anhydrase inhibitor such as topiramate or acetazolamide, at a dose level and/or dosing regimen lower than effective when administered alone.
    Type: Application
    Filed: February 23, 2022
    Publication date: April 25, 2024
    Applicant: NBO PHARMA LLC
    Inventors: Fredric D. PRICE, Barry R. FRANKEL, Dorian BEVEC, Warren WASIEWSKI